In terms of 8 targets screened from Drug Repurposing Hub and CCLE datasets, it is reported that the high expression of CCNA2 is associated with a worse prognosis in PC and is correlated with advanced tumor stage [50]. The gene discussed is CCNA2; the disease is pachyonychia congenita.